Provided by Tiger Trade Technology Pte. Ltd.

Coherus BioSciences

1.42
+0.10007.58%
Post-market: 1.41-0.0100-0.70%19:47 EDT
Volume:1.57M
Turnover:2.18M
Market Cap:218.99M
PE:-1.42
High:1.44
Open:1.32
Low:1.32
Close:1.32
52wk High:2.62
52wk Low:1.09
Shares:154.22M
Float Shares:136.00M
Volume Ratio:0.85
T/O Rate:1.15%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0011
EPS(LYR):1.43
ROE:-178.39%
ROA:-30.52%
PB:3.60
PE(LYR):0.99

Loading ...

Coherus Oncology Q1 Sales USD 12.31 Million VS. Ibes Estimate USD 14.3 Million

THOMSON REUTERS
·
May 12

Coherus Oncology Q1 EPS USD -0.28

THOMSON REUTERS
·
May 12

Coherus Oncology Q1 Adjusted Net Income USD -33.925 Million

THOMSON REUTERS
·
May 12

Coherus Oncology Initiated at Buy by Guggenheim

Dow Jones
·
May 12

Guggenheim starts Coherus with Buy on anti-tumor potential

TIPRANKS
·
May 11

Coherus Oncology Inc : Guggenheim Initiates Coverage With Buy Rating; Target Price $12

THOMSON REUTERS
·
May 11

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
May 11

Coherus Oncology Inc expected to post a loss of 27 cents a share - Earnings Preview

Reuters
·
May 09

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
May 08

Coherus Oncology schedules first-quarter 2026 results conference call

Reuters
·
May 04

NervGen Pharma appoints Keith Vendola as CFO

Reuters
·
Apr 27

Coherus Oncology announces annual shareholder meeting

Reuters
·
Apr 10

Coherus BioSciences Charts Leaner Path After Earnings Call

TIPRANKS
·
Apr 03

Coherus Oncology (CHRS) Revenue Gains Contrast With Persistent US$46 Million Quarterly Losses

Simply Wall St.
·
Mar 11

Analysts Offer Insights on Healthcare Companies: Evotec AG (EVO) and Coherus Biosciences (CHRS)

TIPRANKS
·
Mar 11

Coherus Oncology Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
Mar 10

CORRECTED-Coherus Oncology Q4 revenue misses estimates

Reuters
·
Mar 10

Coherus BioSciences Q4 Adj. EPS $(0.34), Inline, Sales $12.748M Miss $13.944M Estimate

Benzinga Earnings
·
Mar 10

Coherus Oncology FY 2025 LOQTORZI net revenue more than doubled to USD 40.8 million

Reuters
·
Mar 10

BRIEF-Coherus Oncology Q4 Sales USD 12.748 Million Vs. IBES Estimate USD 13.9 Million

Reuters
·
Mar 10